Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukaemia
Courtney D. DiNardo, Harry P. Erba, Sylvie D. Freeman, et al.
The Lancet (2023) Vol. 401, Iss. 10393, pp. 2073-2086
Open Access | Times Cited: 165

Showing 26-50 of 165 citing articles:

Prognostic value of dynamic measurable residual disease monitoring by multi-flowcytometry in elderly patients with non-intensively treated acute myeloid leukemia
Yue Sun, Xiaofeng Han, Yiwei Zhang, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Prediction model establishment of prognosis factors for acute myeloid leukemia based on the SEER database
Gangping Li, Di Zhang, Yuewen Fu
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advances of signal transducer and activator of transcription 3 inhibitors in acute myeloid leukemia (Review)
Hui Cheng, Li Chen, Chongmei Huang
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
We still need to hit hard in acute myeloid leukemia, but only in the right patients
Arnold Ganser
Haematologica (2025)
Open Access
Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia
Zhe Zhao, Dongmei Wang, Xue Sheng, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
Xia Zhang, Yuyu Liu, Qinming Hou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia
Haihui Zhuang, Fenglin Li, Renzhi Pei, et al.
Biochemical Genetics (2025)
Closed Access
Decoding the Implications of Zinc in the Development and Therapy of Leukemia
Bo Zhu, Chunhao Yang, Siqi Hua, et al.
Advanced Science (2025)
Open Access
The Multifaceted Roles of BACH1 in Disease: Implications for Biological Functions and Therapeutic Applications
Xiangxiang Wei, Yunquan He, Yueyang Yu, et al.
Advanced Science (2025)
Open Access
Patterns and variations of copy number alterations in acute myeloid leukemia: insights from the LeukAtlas database
Yanxun Su, Zhenxian Han, Yutong Ji, et al.
Leukemia (2025)
Closed Access
Synthesis and Anti-acute Myeloid Leukemia Activity of Cyclopropane-1,1-diamide Derivatives Containing Imidazo[1,2-a]pyridine
L. Eduardo Wu, Jiangdong Li, Zhonghua Shi, et al.
Chinese Journal of Organic Chemistry (2025) Vol. 45, Iss. 1, pp. 286-286
Closed Access
HSPG2 could promote normal haematopoiesis in acute myeloid leukaemia patients after complete remission by repairing bone marrow endothelial progenitor cells
Chen‐Yuan Li, Zhenkun Wang, Tong Xing, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
Fei Xie, Ting‐juan Zhang, Xinlong Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
N-Acetyl-L-Cysteine Promoted Hematopoietic Recovery in Patients with Acute Myeloid Leukemia after Complete Remission--A Pilot Study
Xiaojun Huang, Lijuan Hu, Chenyuan Li, et al.
(2025)
Closed Access
Mebendazole induces ZBP-1 mediated PANoptosis of acute myeloid leukemia cells by targeting TUBA1A and exerts antileukemia effect
Wei Yang, Ying Xu, Shuai Liu, et al.
Journal of Advanced Research (2025)
Open Access
Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome
Yun Wang, Ting‐juan Zhang, Liu-chao Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response
Valeria Mezzanotte, Giovangiacinto Paterno, Ilaria Cerroni, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1254-1254
Open Access
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
Mingyue Yao, Wenzhong Yan, Wang Yf, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Green Tea Catechins: A Promising Anticancer Approach for Leukaemia
Łukasz Mazur, Radosław Balwierz, Karol Michalak, et al.
Planta Medica (2025)
Closed Access
Development of a clinical prediction model for sensitivity to combination therapy of Bcl-2 inhibitors and hypomethylating agents in elderly/unfit patients with acute myeloid leukemia
Yufeng Du, Chunhong Li, Yonghong Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Gene Mutation Characteristics and Prognostic Significance in Acute Myeloid Leukemia Patients From Northeast China
Yiyang Shen, Shuang Fu, Xuan Liu, et al.
Human Mutation (2025) Vol. 2025, Iss. 1
Open Access
Unveiling lactylation modification: A new hope for cancer treatment
Yuxiang Luo, Ning Zhang, Jiarong Ye, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117934-117934
Closed Access
A rapid and green analytical strategy to determine menin inhibitor revumenib in human blood serum via CE-DAD
Sergio Fernández-Trujillo, Gregorio Castañeda, Juana Rodrı́guez, et al.
Microchemical Journal (2025), pp. 113119-113119
Closed Access
Helper ILCs in the human hematopoietic system
Xiaoyu Su, Zhaoqun Deng, Yu Lan, et al.
Trends in Immunology (2025)
Closed Access
Complementing therapeutic strategies for acute myeloid leukemia: signaling pathways and targets of traditional Chinese medicine
Qiaoliang Wu, Lei Zhong, Guibing Zhang, et al.
Leukemia Research (2025) Vol. 151, pp. 107672-107672
Closed Access

Scroll to top